[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Forte Biosciences Inc (FBRX)

Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Forte Biosciences Inc 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 USA

www.fortebiorx.com Employees: 19 P: 310-618-6994

Sector:

Medical

Description:

Forte Biosciences Inc. is a clinical stage, dermatology company. It engages in developing biotherapeutic, FB-401, for the treatment of inflammatory skin diseases which is in clinical stage. Forte Biosciences Inc., formerly known as Tocagen Inc., is based in Sherman Oaks, California.

Key Statistics

Overview:

Market Capitalization, $K 389,224
Enterprise Value, $K 312,264
Shares Outstanding, K 13,886
Float, K 13,067
% Float 94.10%
Short Interest, K 844
Short Float 6.07%
Days to Cover 1.49
Short Volume Ratio 0.72
% of Insider Shareholders 5.90%
% of Institutional Shareholders 77.63%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -69,380 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -24,790 K
EBIT, $ -70,650 K
EBITDA, $ -70,820 K

Growth:

1-Year Return 265.21%
3-Year Return 1.56%
5-Year Return -80.40%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 97.02%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.45 on 03/31/26
Next Earnings Date 05/21/26 [--]
Earnings Per Share ttm -4.77
EPS Growth vs. Prev Qtr -46.46%
EPS Growth vs. Prev Year -70.93%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 08/28/24

FBRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -98.36%
Return-on-Assets % -82.81%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.42
Book Value/Share 4.87
Interest Coverage -4.51
60-Month Beta 3.20
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.